hemophilia A	is a	factor VIII deficiency
hemophilia B	is a	factor IX deficiency
von Willebrand disease	is a	von Willebrand factor deficiency
Factor II deficiency	is a	coagulation factor deficiency
Factor VII deficiency	is a	coagulation factor deficiency
Factor X deficiency	is a	coagulation factor deficiency
Factor V Leiden mutation	is a	thrombophilia
Prothrombin G20210A mutation	is a	thrombophilia
Antithrombin deficiency	is a	thrombophilia
Protein C deficiency	is a	thrombophilia
Protein S deficiency	is a	thrombophilia
Dysfibrinogenemia	is a	coagulation disorder
Afibrinogenemia	is a	coagulation disorder
Hypofibrinogenemia	is a	coagulation disorder
Hyperfibrinolysis	is a	coagulopathy
Disseminated intravascular coagulation	is a	coagulopathy
Liver disease	causes	coagulopathy
Chronic liver disease	causes	coagulopathy
Acute liver failure	causes	coagulopathy
Vitamin K deficiency	causes	prolonged prothrombin time
Warfarin therapy	prolongs	prothrombin time
Heparin therapy	prolongs	activated partial thromboplastin time
Direct oral anticoagulants therapy	prolongs	coagulation tests
Fresh frozen plasma	used for	rapid reversal of coagulopathy
Cryoprecipitate	provides	fibrinogen
Fibrinogen concentrate	treats	hypofibrinogenemia
Prothrombin complex concentrate	reverses	warfarin effects
Desmopressin	treats	von Willebrand disease
Tranexamic acid	inhibits	fibrinolysis
Aminocaproic acid	inhibits	fibrinolysis
Protamine sulfate	reverses	heparin
Vitamin K	reverses	warfarin effects
Factor VIII concentrate	treats	hemophilia A
Factor IX concentrate	treats	hemophilia B
Von Willebrand factor concentrate	treats	von Willebrand disease
Platelet transfusion	treats	severe thrombocytopenia
Immune thrombocytopenia	causes	mucosal bleeding
Thrombotic thrombocytopenic purpura	associated with	microangiopathic hemolytic anemia
Hemolytic uremic syndrome	causes	renal failure
Disseminated intravascular coagulation	features	simultaneous thrombosis and bleeding
Disseminated intravascular coagulation	triggers	sepsis
Sepsis	associated with	DIC
Massive transfusion	increases	coagulopathy
Splenomegaly	causes	thrombocytopenia
Hemarthrosis	occurs with	hemophilia A
Hemarthrosis	occurs with	hemophilia B
Postpartum hemorrhage	occurs with	obstetric coagulopathy
Mucosal bleeding	occurs with	platelet disorders
Epistaxis	occurs with	coagulopathy
Hematoma	occurs with	coagulopathy
Intracranial hemorrhage	is a	life-threatening complication
D-dimer	is a	marker of clot formation
Prothrombin time	measures	extrinsic pathway
International normalized ratio	measures	prothrombin time
INR	is a	measure of coagulation status
Activated partial thromboplastin time	assesses	intrinsic pathway function
Thrombin time	assesses	fibrinogen function
Bernard-Soulier syndrome	is a	platelet adhesion defect
Glanzmann thrombasthenia	is a	platelet aggregation defect
Platelet count	measures	platelet number
Platelet adhesion defect	is a	platelet function abnormality
Platelet aggregation defect	is a	platelet function abnormality
Mucosal bleeding	is a	bleeding symptom
Epistaxis	is a	bleeding symptom
Gingival bleeding	is a	bleeding symptom
Venous thromboembolism	is a	thrombotic event
Hypercoagulable state	predisposes	venous thrombosis
Aspirin	inhibits	platelet aggregation
Clopidogrel	inhibits	platelet aggregation
Rivaroxaban	is a	direct oral anticoagulant
Apixaban	is a	direct oral anticoagulant
Edoxaban	is a	direct oral anticoagulant
Warfarin	is a	oral anticoagulant
Liver failure	increases	bleeding risk
Severe thrombocytopenia	increases	bleeding risk
Vitamin K deficiency	presents with	ecchymosis
Ecchymosis	is a	bleeding sign
Transfusion reaction	occurs with	platelet transfusion
Massive transfusion protocol	used for	warfarin reversal
Plasma exchange	used for	thrombotic thrombocytopenic purpura
Factor replacement therapy	reduces	mortality from bleeding
Blood bank	provides	plasma products
Transfusion medicine	coordinates	coagulation management
Sepsis	increases	DIC risk
Postpartum period	increases	postpartum hemorrhage risk
D-dimer	elevated in	disseminated intravascular coagulation
Fibrin degradation products	increase	bleeding risk
Transfusion threshold	defines	transfusion need
PCC	reverses	warfarin effects
Fibrinogen level	reflects	plasma fibrinogen
Pregnancy	increases	risk of obstetric bleeding
Hepatic synthetic dysfunction	reduces	coagulation factor production
Procoagulant therapy	used for	bleeding control
Transfusion	associated with	transfusion-related complications
Renal impairment	increases	bleeding risk
Neonate	presents with	vitamin K deficiency
Vitamin K dependent factors	are	coagulation factors
Platelet transfusion	used for	active bleeding with thrombocytopenia
Hepatic disease	worsens	coagulopathy
Hemostasis	requires	coagulation pathways
